Principais notícias

Ações

Ipsen completes acquisition of Kartos Therapeutics

The French biopharmaceutical company said it has finalized the purchase of Kartos Therapeutics to strengthen its oncology pipeline.

Ipsen headquarters in France

Mais notícias de França

Explicações do Mercado Francês